SELLAS Life Sciences Group Balance Sheet Health
Financial Health criteria checks 6/6
SELLAS Life Sciences Group has a total shareholder equity of $2.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $15.1M and $12.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$9.15m |
| Equity | US$2.91m |
| Total liabilities | US$12.21m |
| Total assets | US$15.12m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RXK3's short term assets ($12.3M) exceed its short term liabilities ($12.0M).
Long Term Liabilities: RXK3's short term assets ($12.3M) exceed its long term liabilities ($161.0K).
Debt to Equity History and Analysis
Debt Level: RXK3 is debt free.
Reducing Debt: RXK3 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RXK3 has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: RXK3 is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.